Brian K. Halak, Phd

Biography

Brian Halak joined Domain Associates, LLC in 2001 and became a partner in 2006. Dr. Halak currently serves on the board of several life sciences companies, including Alimera Sciences, Dicerna Pharmaceuticals and Kona Medical. He was previously on the board of Esprit Pharma, until the company was acquired by Allergan and Vanda Pharmaceuticals. From 2000 to 2001, Dr. Halak was an associate with Advanced Technology Ventures, where he participated in the firm’s investments in Plexxikon, Percardia and Emphasys. From 1993 to 1995, he was a consultant at the Wilkerson Group, where he developed strategy for pharmaceutical and medical device companies. Dr. Halak holds a bachelor’s degree in engineering from the University of Pennsylvania and a PhD from Thomas Jefferson University. Brian Halak joined Domain Associates, LLC in 2001 and became a partner in 2006. Dr. Halak currently serves on the board of several life sciences companies, including Alimera Sciences, Dicerna Pharmaceuticals and Kona Medical. He was previously on the board of Esprit Pharma, until the company was acquired by Allergan and Vanda Pharmaceuticals. From 2000 to 2001, Dr. Halak was an associate with Advanced Technology Ventures, where he participated in the firm’s investments in Plexxikon, Percardia and Emphasys. From 1993 to 1995, he was a consultant at the Wilkerson Group, where he developed strategy for pharmaceutical and medical device companies. Dr. Halak holds a bachelor’s degree in engineering from the University of Pennsylvania and a PhD from Thomas Jefferson University.

Research Interest

Business